Radiomitigation by melatonin in C57BL/6 mice: possible implications as adjuvant in radiotherapy and chemotherapy
AM Tripathi, S Khan, NK Chaudhury - in vivo, 2022 - iv.iiarjournals.org
Background/Aim: Melatonin (N-acetyl-5-methoxytryptamine), a chief secretory molecule of
the pineal gland, has multiple properties, and numerous clinical investigations regarding its …
the pineal gland, has multiple properties, and numerous clinical investigations regarding its …
Risk factor analysis for the occurrence of severe adverse effects in eribulin treatment
Y Saito, Y Takekuma, T Takeshita, T Noguchi… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: Eribulin is an effective chemotherapeutic agent for the treatment of
metastatic breast cancer and advanced or metastatic soft-tissue sarcomas. However, severe …
metastatic breast cancer and advanced or metastatic soft-tissue sarcomas. However, severe …
Uso do dispositivo Pegfilgrastim OBI para prevenção de neutropenia: revisão de escopo
VP Martins, KDS Mendes, BN Santos… - Acta Paulista de …, 2023 - SciELO Brasil
Objetivo Mapear os cuidados em saúde do dispositivo Pegfilgrastim on-body injector na
prevenção de neutropenia em adultos com câncer em assistência domiciliar após …
prevenção de neutropenia em adultos com câncer em assistência domiciliar após …
Pegfilgrastim OBI device use for neutropenia prevention: a scoping review
VP Martins, KDS Mendes, BN Santos… - Acta Paulista de …, 2023 - SciELO Brasil
Results: A total of 10 articles were included, whose results were subdivided into categories:
patient compliance, health team opinion, patient workload in cancer treatment and device …
patient compliance, health team opinion, patient workload in cancer treatment and device …
Real-world evaluation of supportive care using an electronic health record text-mining tool: G-CSF use in breast cancer patients
SA van Laar, KB Gombert-Handoko… - Supportive Care in …, 2022 - Springer
Purpose Chemotherapy-induced febrile neutropenia (FN) is a life-threatening and
chemotherapy dose-limiting adverse event. FN can be prevented with granulocyte-colony …
chemotherapy dose-limiting adverse event. FN can be prevented with granulocyte-colony …
Detection of risk factors related to administration suspension and severe neutropenia in gemcitabine and nab-paclitaxel treatment
Y Saito, Y Takekuma, M Kobayashi, Y Komatsu… - Supportive care in …, 2021 - Springer
Purpose The combination of gemcitabine (GEM) and nanoparticle albumin-bound paclitaxel
(nab-PTX) is an effective chemotherapeutic regimen for locally advanced and metastatic …
(nab-PTX) is an effective chemotherapeutic regimen for locally advanced and metastatic …
effects of prophylactic administration of granulocyte colony-stimulating factor on peripheral leukocyte and neutrophil counts levels after chemotherapy in patients with …
W Tian, Y Wang, Y Zhou, Y Yao, Y Deng - Frontiers in Oncology, 2022 - frontiersin.org
Background Both chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN)
frequently occur and can lead to dose-limiting toxicity and even fatal chemotherapy side …
frequently occur and can lead to dose-limiting toxicity and even fatal chemotherapy side …
Profiling risk factors for separation of infection complications in patients with gastrointestinal and nodal diffuse large B-cell lymphoma
M Xue, Z Gao, M Yan, Y Bao - BMC Infectious Diseases, 2023 - Springer
Objective To identify risk factors for infection complications in patients with gastrointestinal
diffuse large B-cell lymphoma (GI-DLBCL) and nodal DLBCL (N-DLBCL) during treatment …
diffuse large B-cell lymphoma (GI-DLBCL) and nodal DLBCL (N-DLBCL) during treatment …
A phase II study of FOLFIRINOX with primary prophylactic pegfilgrastim for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer
M Sasaki, H Ueno, S Mitsunaga, A Ohba… - International Journal of …, 2021 - Springer
Background Although FOLFIRINOX is currently one of the standard therapies for
chemotherapy-naïve patients with metastatic pancreatic cancer (MPC), the high rate of …
chemotherapy-naïve patients with metastatic pancreatic cancer (MPC), the high rate of …
Inflammation Control and Tumor Growth Inhibition of Ovarian Cancer by Targeting Adhesion Molecules of E-Selectin
B Yang, S Yin, Z Zhou, L Huang, M Xi - Cancers, 2023 - mdpi.com
Simple Summary The aim of our study is to use E-selectin-binding peptide (ESBP) to actively
recognize E-selectin, so allowing a drug delivery system to actively recognize the cells and …
recognize E-selectin, so allowing a drug delivery system to actively recognize the cells and …